The mechanism of apoptosis induced by treatment with As 2 O 3 alone or in combination with buthionine sulfoximine (BSO) was studied in NB4, U937, Namalwa, and Jurkat cells. As 2 O 3 at concentrations <2 Mmol/L induced apoptosis in NB4 cells and Namalwa cells but not in U937 and Jurkat cells. As 2 O 3 -induced apoptosis in NB4 cells and Namalwa cells correlated with increase of H 2 O 2 and caspase activation without activation of c-Jun NH 2 -terminal kinase (JNK). BSO (10 Mmol/L) depleted the reduced form of intracellular glutathione without inducing apoptosis but synergized with 1 Mmol/L As 2 O 3 to induce apoptosis in all four cell lines. This synergy correlated with JNK activation. Treatment with As 2 O 3 plus BSO, but not with As 2 O 3 alone, increased the levels of death receptor (DR) 5 protein and caspase-8 cleavage. The JNK inhibitor SP600125 inhibited the increase in DR5 protein and attenuated apoptosis induced by treatment with As 2 O 3 plus BSO. These observations suggest that a DR-mediated pathway activated by JNK is involved in apoptosis induced by treatment with As 2 O 3 plus BSO. (Cancer Res 2006; 66(23): 11416-23) 
Introduction
As 2 O 3 treatment induces clinical remission in acute promyelocytic leukemia (APL) patients (1) (2) (3) . Mechanism studies suggest that both apoptosis and partial differentiation induction account for the therapeutic effect of As 2 O 3 in APL patients (4, 5) . Although clinical trials using As 2 O 3 in other forms of leukemia, lymphoma, and solid tumors have been initiated, therapeutic effects as in APL have not been observed (6) (7) (8) . Combination of other agents with As 2 O 3 has shown improvement in therapeutic effectiveness in vitro and in vivo (9) (10) (11) (12) . As 2 O 3 at low concentrations (1-2 Amol/L) selectively induces apoptosis in APL-derived NB4 cells and in some lymphoma cells, whereas other leukemia cells and solid tumor cells are insensitive to As 2 O 3 -induced apoptosis (13) (14) (15) . As 2 O 3 induces apoptosis in APL cells through a mitochondria-mediated pathway resulting from the accumulation of H 2 O 2 (10, 16, 17) . Leukemia and lymphoma cells with lower intracellular levels of reduced glutathione (GSH) are much more sensitive to As 2 O 3 -induced apoptosis than cells with higher levels (10, 18) . Agents with the ability to decrease intracellular GSH levels enhance As 2 O 3 -induced apoptosis (10, 19, 20) . Among the agents that enhance As 2 O 3 -induced apoptosis, buthionine sulfoximine (BSO) is the most effective (17, 21, 22) .
In the present study, the apoptotic induction ability and mechanism of As 2 O 3 alone and in combination with BSO were compared in two leukemia and two lymphoma cell lines in vitro. The data indicate that As 2 O 3 induces apoptosis at low concentrations in NB4 and Namalwa cells, but not in U937 and Jurkat cells, through a H 2 O 2 -mediated pathway. This pathway can be inhibited by the antioxidant N-acetylcysteine (NAC). However, As 2 O 3 in combination with BSO synergistically induced apoptosis in all the cell lines tested primarily through activation of c-Jun NH 2 -terminal kinase (JNK), which up-regulated death receptor (DR) 5 and the caspase-8-mediated pathway.
Materials and Methods
Reagents. As 2 O 3 (0.1%) solution was kindly supplied by Cell Therapeutic, Inc. (Seattle, WA) BSO, ethidium bromide (EB), acridine orange (AO), NAC, catalase, and SP600125 were purchased from Sigma Chemical Co. (St. Louis, MO). Z-VAD-FMK and Z-IETD-FMK were obtained from Calbiochem (La Jolla, CA). Antibodies to Bcl-2 and poly(ADP-ribose) polymerase (PARP) were obtained from Roche Diagnostics Corp. (Indianapolis, IN). Caspase-3 and caspase-8 were from BD Biosciences (San Diego, CA). DR5 and DR4 were from Axxora (San Diego, CA). Bid, JNK, p38, extracellular signal-regulated kinase (ERK), and phosphorylated ERK (p-ERK) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Phosphorylated JNK (p-JNK), phosphorylated p38 (p-p38), and InBa were from Cell Signaling Technology (Beverly, MA).
Cell lines. U937 and NB4 leukemia cells were cultured in RPMI 1640 supplemented with 100 units/mL penicillin, 100 Ag/mL streptomycin, 1 mmol/L L-glutamine, and 10% heat-inactivated fetal bovine serum (FBS). Namalwa and Jurkat human lymphoma cells were cultured in RPMI 1640 adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mmol/L HEPES, 1.0 mmol/L sodium pyruvate, 100 units/mL penicillin, 100 Ag/mL streptomycin, and 10% FBS. Cells in logarithmic growth were seeded at 1 Â 10 5 per mL for studies. Quantitation of apoptotic cells. Apoptotic cells were examined morphologically after staining with AO and EB (10) and by using fluorescence-activated cell sorting (FACS) after staining with Annexin V-FITC (23) . For morphologic analysis, briefly, 1 AL of stock solution containing 100 Ag/mL AO and 100 Ag/mL EB was added to 25 AL cell suspension. The apoptotic cells (i.e., those showed nuclear shrinkage and blebbing) and apoptotic bodies were analyzed with the aid of a fluorescence microscopy. The percentage of apoptotic cells was calculated after counting total 300 cells. For FACS analysis, about 5 Â 10 5 to 10 Â 10 5 cells were washed twice with PBS and then labeled with Annexin V-FITC and propidium iodide (PI) in medium-binding reagent according to the Annexin V-FITC apoptosis detection kit instruction provided by the manufacturer (Oncogene, Cambridge, MA). Fluorescent signals of FITC and PI were detected respectively at 518 nm and at 620 nm on FACScan (Becton Dickinson, San Jose, CA). The log of Annexin V-FITC fluorescence was displayed on the X axis and the log of PI fluorescence was displayed on the Y axis. The data were analyzed by the CellQuest program (Becton Dickinson). For each analysis, 10,000 events were recorded. Intracellular H 2 O 2 production. Intracellular H 2 O 2 levels were determined, as reported previously, using 5,6-carboxy-2 ¶,7 ¶-dichlorofluorescein diacetate (DCFH-DA; Molecular Probes, Eugene, OR; ref. 14). Briefly, 2 hours before ending the indicated treatment, 0.5 Amol/L DCFH-DA was added to the medium. The fluorescence intensity was measured by FACScan.
Measurement of intracellular GSH. Intracellular GSH contents were measured using a Glutathione Assay kit (Calbiochem, San Diego, CA). In brief, 5 Â 10 6 cells were homogenized in 5% metaphosphoric acid using a Teflon pestle (Racine, WI). Particulate matter was separated by centrifugation at 4,000 Â g. The supernatant solution was used for GSH measurement according to the manufacturer's instructions. The GSH content was expressed as nmol/10 6 cells. Western blot analysis. Cells were centrifuged, washed with cold PBS, and lysed on ice for 30 minutes in radioimmunoprecipitation assay buffer (1Â PBS, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease and phosphatase inhibitors [1 mmol/L phenylmethylsulfonyl fluoride, 1 mmol/L Na 3 VO 4 , 5 mmol/L NaF, and 1Â protease inhibitor (Boehringer Mannheim GmbH, Mannheim, Germany)]. Protein concentrations were determined with a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA). Total protein (50 Ag) was electrophoresed on 8% to 12% SDS polyacrylamide gels and transferred to nitrocellulose membranes (Amersham, Piscataway, NJ). After incubating with 5% nonfat milk for 1 hour, the membranes were incubated with the primary antibody indicated overnight at 4jC, washed with TBS (pH 6.8) and Tween 20 (TBS-T) thrice, incubated with secondary antibody for an hour at room temperature, and washed with TBS-T thrice. The immunocomplex was visualized by enhanced chemiluminescence Western blotting detection reagents (Amersham Biosciences, Buckinghamshire, United Kingdom).
Statistics. Data were analyzed for statistical significance using the Student's t test (Microsoft Excel, Microsoft Corp., Seattle, WA). Differences were considered significant at P < 0.05.
Results
As 2 O 3 at concentrations below 2 Mmol/L induces apoptosis in NB4 and Namalwa cells but not in Jurkat and U937 cells. The apoptotic induction ability of As 2 O 3 in NB4, U937, Namalwa, and Jurkat cells after treatment at concentrations of 1 to 2 Amol/L for 1 to 3 days was compared. As 2 O 3 induced apoptosis at 1 Amol/L in NB4 cells but not in Namalwa, Jurkat, and U937 cells (Fig. 1A) . When As 2 O 3 concentration was increased to 2 Amol/L, apoptotic cells were observed in both NB4 and Namalwa cells but not in Jurkat and U937 cells (Fig. 1B) . These results as well as those in previous reports indicate that As 2 O 3 selectively induces apoptosis in some but not all leukemia and lymphoma cells (14, 15, 17) .
As 2 O 3 -induced apoptosis correlates with increase of H 2 O 2 accumulation and caspase-3 activation among the four cell lines. Several pathways have been reported to mediate As 2 O 3 -induced apoptosis (14, 21, 24, 25) and some factors involved in these pathways have been examined here. As shown in Fig. 2A , As 2 O 3 at 2 Amol/L induced PARP cleavage and decreased procaspase-3 levels in NB4 and Namalwa cells. These findings correlate with apoptotic induction (Fig. 1B) . The protein levels of Bcl-2, ERK, JNK, and p38 were not changed by As 2 O 3 treatment in any of these cell lines even to those where it induced apoptosis. ERK, p38, and JNK activation was investigated by comparing the levels of their phosphorylated forms to their nonphosphorylated ones. p-ERK was detected in all of the cell lines, but the levels of its phosphorylated form were not changed by As 2 O 3 treatment. p-JNK was not detected or induced in any of these cell lines before or after As 2 O 3 treatment. Low levels of p-p38 were present in all of the cell lines. As 2 O 3 treatment weakly increased the levels of p-p38 in NB4 and U937 cells but not in Namalwa and Jurkat cells ( Fig. 2A) .
Because we have shown previously that caspase-3-mediated PARP cleavage was due to increased intracellular H 2 O 2 , which results in decreased mitochondria membrane potentials in NB4 cells (14) , H 2 O 2 levels were compared among these cell lines before or after As 2 O 3 treatment at 2 Amol/L (Fig. 2B) . H 2 O 2 levels were increased in NB4 and Namalwa cells, but not in U937 and Jurkat cells, after As 2 O 3 treatment. To further show that H 2 O 2 is a key factor in this apoptotic induction, antioxidant NAC, which can reduce H 2 O 2 levels, was used. NAC blocked As 2 O 3 -induced apoptosis in NB4 and Namalwa cells (Fig. 2C) . A general caspase inhibitor, Z-VAD-FMK, also blocked As 2 O 3 -induced apoptosis in both cell lines (Fig. 2C) .
To further investigate whether JNK activation is involved in As 2 O 3 -induced apoptosis, NB4 and U937 cells were treated with 1 to 6 Amol/L for 24 hours. Although As 2 O 3 inhibited cell growth in both cell lines (Fig. 3A) , it induced apoptosis in 85% of NB4 cells, whereas only 12% of the U937 cells after 6 Amol/L treatment ( Fig. 3B ). High concentrations of As 2 O 3 (up to 6 Amol/L) were required to cause slight changes in PARP cleavage or procaspase-3 levels in U937 cells (Fig. 3C ). The Synergistic Apoptotic Induction of As 2 O 3 with BSO www.aacrjournals.org BSO synergizes with As 2 O 3 to induce apoptosis by activating both JNK and caspases. NB4, U937, Namalwa, and Jurkat cells were treated with either 1 Amol/L As 2 O 3 or 10 Amol/L BSO alone or in combination for 24 or 48 hours (Fig. 4A) . Neither BSO nor As 2 O 3 alone significantly induced apoptosis in these cell lines after treatment at this short time period. However, BSO in combination with As 2 O 3 synergistically induced apoptosis in all of these lines. BSO depleted intracellular GSH levels in all of these cell lines (Fig. 4B) . BSO in combination with As 2 O 3 induced PARP cleavage and decreased procaspase-3 levels in all of these cell lines (Fig. 4C) . None of the treatments altered the levels of Bcl-2 protein (Fig. 4C) . As 2 O 3 and BSO treatment strongly induced level of p-JNK and weakly induced level of p-p38 in all cell lines (Fig. 4D) .
U937 and Jurkat cells were treated with 1 Amol/L As 2 O 3 in combination with 10 Amol/L BSO for 6 to 72 hours to further investigate the induced apoptotic pathways. As 2 O 3 plus BSO significantly induced apoptosis in both cell lines after 48 hours of treatment (Figs. 4A and 5A ). Time course of the protein levels of PARP, procaspase-3, p-JNK, and p-p38 were determined in both cell lines after treatment with As 2 O 3 in combination with BSO (Fig. 5B) . PARP and procaspase-3 cleavages were correlated with increased levels of p-JNK in both cell lines. p-p38 was significantly increased in U937 cells but not in Jurkat cells. These data suggest that both caspase-and JNK-activated pathways may contribute to As 2 O 3 plus BSO-induced apoptosis.
H 2 O 2 levels were measured in U937 cells after treatment with As 2 O 3 plus BSO. As shown in Fig. 5C , H 2 O 2 increased in U937 cells Figure 4 . Effects of As 2 O 3 combined with BSO on apoptotic induction and specific protein levels. A, apoptotic cells. Cells were treated with and without 1 Amol/L As 2 O 3 , 10 Amol/L BSO, and their combination for 24 hours for NB4 and Namalwa cells and for 48 hours for U937 and Jurkat cells. The percentage of apoptotic cells was determined with the aid of a fluorescence microscope after staining with AO and EB. B, GSH levels. The cells were incubated in the absence and presence of 10 Amol/L BSO for 48 hours. GSH levels were measured using GSH detection kits as described in Materials and Methods. C, PARP, caspase-3, and Bcl-2 levels. D, ERK, p38, and JNK as well as their phosphorylated forms. Cells were incubated with and without 1 Amol/L As 2 O 3 , 10 Amol/L BSO, and their combination for 24 hours for NB4 and Namalwa cells and 48 hours for U937 and Jurkat cells. The level of each protein was detected using specific antibodies as described in Materials and Methods.
after treatment with As 2 O 3 plus BSO. NAC or catalase blocked H 2 O 2 accumulation (Fig. 5C ) but not apoptotic induction in U937 cells (Fig. 5D) . Moreover, NAC and catalase did not block JNK activation in U937 cells after treatment with As 2 O 3 plus BSO (data not shown). These results suggest that increased H 2 O 2 production is not necessary in As 2 O 3 plus BSO-induced apoptosis.
DR5 is increased in apoptotic cells after treatment with As 2 O 3 in combination with BSO. DR4 and DR5 protein levels were measured in U937 cells after treatment with As 2 O 3 or BSO alone and in combination. DR4 was highly expressed in U937 cells and its level was not increased after treatment by either agent alone or in combination (Fig. 6A) . DR5 was weakly expressed in U937 cells and its level was induced after treatment with As 2 O 3 plus BSO but not after treatment with either agent alone. Correlated with the DR5 induction, procaspase-8 and Bid protein levels were cleaved in U937 cells after treatment with As 2 O 3 plus BSO but not after treatment with either agent alone. These data suggest that DR5, but not DR4, participate in As 2 O 3 plus BSOinduced apoptosis. Recently, it has been found that DR5 levels can be increased by JNK activation (26) . To investigate a possible connection between JNK activation and DR5 induction in As 2 O 3 plus BSO-treated cells, JNK inhibitor SP600125 was used. PARP and procaspase-8 cleavages, increased p-JNK, and DR5 protein levels after treatment with As 2 O 3 plus BSO were inhibited after the addition of SP600125 (Fig. 6B) . These data suggest that activated JNK increases DR5 protein levels, which in turn mediates As 2 O 3 plus BSO-induced apoptosis.
Caspase inhibitor, Z-VAD-FMK, and JNK inhibitor, SP600125, inhibited apoptosis induced by As 2 O 3 in combination with BSO. The requirement of caspase activation or JNK activation in combination treatment-induced apoptosis was evaluated by using a JNK inhibitor, SP600125, and a caspase inhibitor, Z-VAD-FMK. Both agents significantly inhibited As 2 O 3 plus BSO-induced apoptosis in U937 cells (Fig. 6C) . These results suggest that both caspase-and JNK-mediated pathways participate in As 2 O 3 plus BSO-induced apoptosis.
Discussion
As 2 O 3 is an apoptosis inducer in many kinds of cancer cell lines in vitro and acts in some leukemia and lymphoma cells at very low concentrations (10, 14, 15, 17, 24, 27, 28) . Among the leukemia and lymphoma cells, APL and B-cell lymphoma cells are more sensitive to As 2 O 3 -induced apoptosis than other types of leukemia and lymphoma cells (14, 15, 17) . One of the reasons to account for this selectivity has been thought to be, at least partially, due to lower levels of cellular GSH (10, 29) . However, Jurkat cells containing lower levels of GSH than NB4 cells (Fig. 4B) are not sensitive to As 2 O 3 -induced apoptosis at the low concentration (1 Amol/L; Fig. 1B) , suggesting that other factors may compensate for the lower levels of GSH and account for their insensitivity to As 2 O 3 treatment. Because As 2 O 3 induces apoptosis at low concentrations through a H 2 O 2 -mediated pathway (Fig. 2B and C) , one possibility might be higher cellular levels of glutathione peroxidase and glutathione-S-transferase (14, 23) , which scavenge H 2 O 2 catabolism. Because these enzymes use GSH as a substrate to catalyze H 2 O 2 , depletion of GSH will decrease the activities of these enzymes and in turn sensitize the cells to As 2 O 3 -induced apoptosis. Many agents, such as green tea, ascorbic acid, phosphatidylinositol 3-kinase (PI3K)/Akt inhibitor, and BSO enhance As 2 O 3 -induced apoptosis (10, 19, (30) (31) (32) . One common mechanism of these agents that enable them to synergize with As 2 O 3 seems to be due to their ability to decrease intracellular GSH levels. It has been found that the enhanced effect of ascorbic acid on As 2 O 3 -induced apoptosis correlated with the depletion of GSH in myeloma cells and As 2 O 3 in combination with ascorbic acid has been put into clinical trials (19, (33) (34) (35) . Among these agents that depleted intracellular GSH, BSO is the most effective. BSO has been found to enhance As 2 O 3 -induced apoptosis in many types of hemopoietic and solid tumors (10, 17, 22, 36) . Consistent with previous reports, BSO significantly depleted intracellular GSH levels (Fig. 4B ) and enhanced As 2 O 3 -induced apoptosis in both As 2 O 3 -sensitive and As 2 O 3 -insensitive leukemia and lymphoma cells (Fig. 4A ). These data suggest that As 2 O 3 plus BSO might be an effective treatment for leukemias and lymphomas.
Many mechanisms have been proposed to be involved in As 2 O 3 -induced apoptosis [e.g., production of reactive oxygen species (ROS) and activation of caspase through both mitochondrial-dependent and mitochondrial-independent pathways; refs. 14, 16, 37, 38] . Recently, it has been found that JNK and mitogen-activated protein kinase are involved in As 2 O 3 -induced apoptosis (21, (39) (40) (41) . By using NB4 and Namalwa cells which are particularly sensitive to As 2 O 3 -induced apoptosis at low concentrations ( Fig. 1 ), we have found that H 2 O 2 production (Fig. 2B ), but not JNK and p38 activation ( Figs. 2A  and 3C ), is correlated with As 2 O 3 -induced apoptosis. As 2 O 3 induced H 2 O 2 accumulation and caspase-3 activation in NB4 and Namalwa cells ( Fig. 2A and B) . This apoptotic effect was blocked by the antioxidant, NAC, and by the caspase inhibitor, Z-VAD-FMK (Fig. 2C) . As 2 O 3 at this concentration did not activate JNK and p38 ( Fig. 2A) . These results suggest that ROS-mediated signaling is a main pathway of As 2 O 3 -induced apoptosis at low concentrations. Unlike the apoptotic mechanism described above, PARP and caspase-3 cleavages in these cell lines after treatment with As 2 O 3 plus BSO were correlated with an increase of p-JNK (Figs. 4D and 5B). Because the JNK inhibitor SP600125, but not antioxidants NAC and catalase, inhibited the apoptosis induced by combination of As 2 O 3 and BSO (Figs. 5D and 6C) , it seems that JNK activation contributes to As 2 O 3 plus BSO-induced apoptosis through a H 2 O 2 -independent pathway. Recently, it has been found that activated JNK increases the cellular levels of DRs (26) . By comparing the DR4 and DR5, it was found that DR5, but not DR4, was induced after treatment of As 2 O 3 plus BSO but not with each agent alone (Fig. 6A) . Up-regulation of DR5 correlated with caspase-8 activation, JNK activation, and apoptotic induction in U937 cells (Fig. 6B) . Inhibition of JNK by SP600125 decreased DR5 up-regulation and apoptotic induction in U937 cells treated with As 2 O 3 plus BSO (Fig. 6B and C) . Nuclear factor-nB (NF-nB) has been found to contribute to the activation of JNK and upregulation of DR5 (26) . NF-nB activity is inhibited by InBa and it has been found that the InBa protein was regulated by As 2 O 3 treatment (42, 43) . We observed that InBa was degraded by the combination treatment but not either agent alone (Fig. 6A) . The InBa degradation is correlated with JNK activation. These results suggest that As 2 O 3 plus BSO may induce apoptosis through a JNK-regulated DR-mediated pathway due to activation of NF-nB.
